This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Morphic Therapeutic, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Mark Brewer: Innovator in Integrin Inhibitors
Introduction
Mark Brewer is a notable inventor based in Wallingford, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of integrin inhibitors. With a total of 4 patents to his name, Brewer's work is paving the way for new therapeutic approaches.
Latest Patents
Brewer's latest patents focus on small molecule inhibitors of αvβ6 integrin. These patents disclose methods of using these inhibitors to treat various diseases and conditions. The innovative nature of his work lies in the potential applications of these inhibitors in medical treatments.
Career Highlights
Mark Brewer is currently associated with Morphic Therapeutic, Inc., where he continues to advance his research and development efforts. His expertise in integrin inhibitors has positioned him as a key player in the pharmaceutical industry.
Collaborations
Brewer collaborates with talented individuals such as Bryce Alden Harrison and Matthew Gregory Bursavich. Their combined efforts contribute to the innovative research being conducted at Morphic Therapeutic, Inc.
Conclusion
Mark Brewer's contributions to the field of integrin inhibitors highlight his role as an influential inventor. His work not only showcases his innovative spirit but also promises to impact the treatment of various diseases in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile